Adaptyx (Adaptyx Biosciences) develops a minimally‑invasive wearable patch that continuously monitors lab‑grade biochemical markers in interstitial fluid. By converting molecular data into real‑time digital streams, the platform enables AI‑driven, proactive healthcare for conditions such as heart failure, chronic kidney disease, hormone imbalances, and precision pharmacology, reducing the need for frequent clinic visits and lab draws.
No recent news for this company.